Diagnostics
A summary of daily biopharma industry news. Please check out stories that are trending on March 23, 2020.
A summary of daily Biopharma industry news. Please check out stories that are trending on March 20, 2020.
A summary of daily Biopharma industry news. Please check out stories that are trending on March 19, 2020.
As a valued member of our BioSpace community, we are eager to hear more from you and other readers in 2020. We want to know how the coronavirus outbreak may be impacting your work and your workplace.
As the number of diagnosed cases of COVID-19 continue to increase across the globe and more and more governments are urging citizens to self-quarantine, the pharmaceutical and life sciences industry continues to work toward the development of a vaccine and therapies for the respiratory infection that was declared a pandemic by the World Health Organization last week. Here’s a biopharma industry overview as of late March 16.
New study data show that monitoring blood levels of sphingotec’s endothelial function biomarker bio-ADM(R) on top of guideline parameter lactate improves risk stratification of sepsis patients admitted to intensive care units
The global home diagnostics market is witnessing a growth and shall continue to expand at a high pace on account of the rising disposable income of people across nations, which enable them to afford products that enable self care.
Bioactive Adrenomedullin is a biomarker for endothelial dysfunction and allows the prediction of septic shock as elevated blood levels of bio-ADM(R) predict blood pressure break down and blood vessel leakage resulting in edema
Now that global responses are fully mobilized, what is being done to identify and develop drugs and vaccines against this novel coronavirus?
Vela Diagnostics Submitting Novel Coronavirus Diagnostic Test to FDA for Emergency Use Authorization
Vela Diagnostics has developed the ViroKeyTM SA201 COVID-19 RT-PCR Test, a new diagnostic test for the detection of the COVID-19 coronavirus. Vela Diagnostics is currently in discussions with the U.S. Food and Drug Administration for clearance of the test under the emergency use authorization.
PRESS RELEASES